Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Vilazodone hydrochloride, a combined SSRI and 5-HT1A receptor agonist for major depressive disorder.

Guay DR.

Consult Pharm. 2012 Dec;27(12):857-67. doi: 10.4140/TCP.n.2012.857. Review.

PMID:
23229074
2.

Vilazodone: a novel antidepressant.

Choi E, Zmarlicka M, Ehret MJ.

Am J Health Syst Pharm. 2012 Sep 15;69(18):1551-7. doi: 10.2146/ajhp110374. Review.

PMID:
22935937
3.

Vilazodone for the treatment of depression.

Lindsey WT.

Ann Pharmacother. 2011 Jul;45(7-8):946-53. doi: 10.1345/aph.1P772. Epub 2011 Jun 13. Review.

PMID:
21672888
4.

Vilazodone (Viibryd)--a new antidepressant.

[No authors listed]

Med Lett Drugs Ther. 2011 Jul 11;53(1368):53-4. Review.

PMID:
21738107
5.

Vilazodone, a novel dual-acting serotonergic antidepressant for managing major depression.

Khan A.

Expert Opin Investig Drugs. 2009 Nov;18(11):1753-64. doi: 10.1517/13543780903286396. Review.

PMID:
19764890
6.

Vilazodone for the treatment of major depressive disorder.

Iranikhah M, Wensel TM, Thomason AR.

Pharmacotherapy. 2012 Oct;32(10):958-65. doi: 10.1002/j.1875-9114.2012.01121.

PMID:
23033234
7.

Vilazodone: in major depressive disorder.

Frampton JE.

CNS Drugs. 2011 Jul;25(7):615-27. doi: 10.2165/11207550-000000000-00000. Review.

PMID:
21699273
8.

Vilazodone: a new treatment option for major depressive disorder.

Owen RT.

Drugs Today (Barc). 2011 Jul;47(7):531-7. doi: 10.1358/dot.2011.47.7.1622076.

PMID:
22013560
9.

Vilazodone approved for major depression.

Traynor K.

Am J Health Syst Pharm. 2011 Mar 1;68(5):366. doi: 10.2146/news110009. No abstract available.

PMID:
21330672
10.

Early and sustained improvement with vilazodone in adult patients with major depressive disorder: post hoc analyses of two phase III trials.

Jain R, Chen D, Edwards J, Mathews M.

Curr Med Res Opin. 2014 Feb;30(2):263-70. doi: 10.1185/03007995.2013.855188. Epub 2013 Oct 31.

PMID:
24127687
11.

Vilazodone: clinical basis for the US Food and Drug Administration's approval of a new antidepressant.

Laughren TP, Gobburu J, Temple RJ, Unger EF, Bhattaram A, Dinh PV, Fossom L, Hung HM, Klimek V, Lee JE, Levin RL, Lindberg CY, Mathis M, Rosloff BN, Wang SJ, Wang Y, Yang P, Yu B, Zhang H, Zhang L, Zineh I.

J Clin Psychiatry. 2011 Sep;72(9):1166-73. doi: 10.4088/JCP.11r06984. Review.

PMID:
21951984
12.

Vilazodone: a 5-HT1A receptor agonist/serotonin transporter inhibitor for the treatment of affective disorders.

Dawson LA, Watson JM.

CNS Neurosci Ther. 2009 Summer;15(2):107-17. Review.

PMID:
19499624
13.

The discovery and development of vilazodone for the treatment of depression: a novel antidepressant or simply another SSRI?

Dawson LA.

Expert Opin Drug Discov. 2013 Dec;8(12):1529-39. doi: 10.1517/17460441.2013.855195. Epub 2013 Nov 7. Review.

PMID:
24195711
15.

A 1-year, open-label study assessing the safety and tolerability of vilazodone in patients with major depressive disorder.

Robinson DS, Kajdasz DK, Gallipoli S, Whalen H, Wamil A, Reed CR.

J Clin Psychopharmacol. 2011 Oct;31(5):643-6. doi: 10.1097/JCP.0b013e31822c6741.

PMID:
21869687
16.

Vilazodone: another novel atypical antidepressant drug.

Howland RH.

J Psychosoc Nurs Ment Health Serv. 2011 Mar;49(3):19-22. doi: 10.3928/02793695-20110203-98. Epub 2011 Feb 16.

PMID:
21323263
17.

ACS chemical neuroscience molecule spotlight on viibryd (Vilazodone).

Hopkins CR.

ACS Chem Neurosci. 2011 Oct 19;2(10):554. doi: 10.1021/cn200084v. Review.

18.

The effect of vilazodone on sexual function during the treatment of major depressive disorder.

Clayton AH, Kennedy SH, Edwards JB, Gallipoli S, Reed CR.

J Sex Med. 2013 Oct;10(10):2465-76. doi: 10.1111/jsm.12004. Epub 2012 Dec 6.

PMID:
23216998
19.
20.

The efficacy profile of vilazodone, a novel antidepressant for the treatment of major depressive disorder.

Reed CR, Kajdasz DK, Whalen H, Athanasiou MC, Gallipoli S, Thase ME.

Curr Med Res Opin. 2012 Jan;28(1):27-39. doi: 10.1185/03007995.2011.628303. Epub 2011 Nov 23.

PMID:
22106941

Supplemental Content

Support Center